CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 30, 2016	Aug. 01, 2015
Cash flows from operating activities:
Net loss	$ (5,672)	$ (4,906)
Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization	23,324	22,390
Net loss (gain) on asset disposition	320	(107)
Provision (benefit) for store closures and asset impairment	77	315
Stock-based compensation	1,496	928
Provision (benefit) for uncollectible receivables	(767)	824
LIFO reserve increase	1,087	3,281
Deferred income tax benefit	(4,343)	(3,511)
Income tax charge (benefit) upon exercise of stock options	11	(214)
Amortization of debt issuance costs	53	101
(Increase) decrease in operating assets:
Trade and non-trade receivables	(95)	(8,675)
Insurance receivables	473	(189)
Inventories	(6,711)	(9,189)
Other assets	1,066	1,951
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	(36,502)	3,947
Income taxes payable	3,204	8,443
Other noncurrent liabilities	(3,004)	(2,464)
Net cash provided by (used in) operating activities	(25,983)	12,925
Cash flows provided by (used in) investing activities:
Capital expenditures	(13,126)	(10,301)
Proceeds from asset dispositions	426	246
Insurance recoveries for replacement assets	263
Asset acquisition, net (primarily intangibles)	(9,157)	(6,533)
Acquisition of Reeves-Sain Drug Store, Inc., net of cash		(42,757)
Net cash used in investing activities	(21,594)	(59,345)
Cash flows provided by (used in) financing activities:
Proceeds from revolving line of credit	490,752	451,004
Payments on revolving line of credit	(438,080)	(401,004)
Payments of indebtedness and capital lease obligations	(592)	(510)
Debt issuance costs		(511)
Excess tax charges (benefit) from stock-based compensation	(11)	214
Proceeds from exercise of stock options and employee stock purchase plan	251	2,199
Cash dividends paid	(4,479)	(4,448)
Net cash provided by financing activities	47,841	46,944
Increase in cash and cash equivalents	264	524
Cash and cash equivalents:
Beginning of year	5,917	6,440
End of period	6,181	6,964
Supplemental disclosures of cash flow information:
Interest paid	1,125	711
Income taxes paid (refunded)	(2,472)	3,849
Non-cash investing and financial activities:
Acquisition related note payable, see Note 11 - Business Combinations		$ 13,000